Lum Lionel, Lee Andie, Vu Monica, Strasser Simone, Davis Rebecca
Department of Infectious Diseases and Microbiology, Royal Prince Alfred Hospital, Sydney, NSW, Australia.
Faculty of Medicine, University of Sydney, Sydney, NSW, Australia.
Transpl Infect Dis. 2020 Dec;22(6):e13361. doi: 10.1111/tid.13361. Epub 2020 Jun 22.
Invasive fungal disease (IFD) in liver transplant recipients causes significant morbidity and mortality. We aim to describe institutional epidemiology and risk factors for IFD in the liver transplant population.
We conducted a retrospective cohort study of all adult liver transplant recipients in our institution from 2005 to October 2015 to describe the epidemiology of patients with proven and probable IFD according to the European Organization for Research and Treatment of Cancer/Mycoses Study Group criteria. To determine risk factors for IFD, a case-control study was also conducted. Cases were defined as liver transplant recipients with proven or probable IFD, and controls were defined as liver transplant recipients without IFD. Each case was matched to two controls by age (±10 years of age), gender, and time of transplant (within one year of the case).
28/554 (5.1%) patients developed IFD. Candidiasis (n = 11; 39.3%), Aspergillosis (n = 10; 35.7%), and Cryptococcosis (n = 3; 10.7%) were the most common fungal infections in the proven and probable IFD groups. Mold infections occurred in 13 (46.4%) cases. Reoperation, roux-en-y anastomosis, and massive intraoperative transfusion of ≥40 units of cellular blood products were major risk factors for IFD in the multivariate analysis.
Candida and Aspergillus are the most common causes of IFD in liver transplantation in our center. There is significant overlap in risk factors for such infections post-transplantation. In our cohort, critically ill patients with complicated perioperative course seem to predispose them to mold infections post-transplantation, but larger studies are required to better delineate risk factors for mold infection as well as determine the efficacy and optimal duration of mold prophylaxis in liver transplantation. With increasing echinocandin use for antifungal prophylaxis, it is also important to monitor for emerging antifungal resistance.
肝移植受者的侵袭性真菌病(IFD)可导致显著的发病率和死亡率。我们旨在描述肝移植人群中IFD的机构流行病学及危险因素。
我们对2005年至2015年10月期间在本机构接受肝移植的所有成年受者进行了一项回顾性队列研究,以根据欧洲癌症研究与治疗组织/真菌病研究组标准描述确诊和疑似IFD患者的流行病学情况。为确定IFD的危险因素,还进行了一项病例对照研究。病例定义为确诊或疑似IFD的肝移植受者,对照定义为无IFD的肝移植受者。每个病例按年龄(±10岁)、性别和移植时间(病例的1年内)与两名对照进行匹配。
28/554(5.1%)例患者发生IFD。念珠菌病(n = 11;39.3%)、曲霉病(n = 10;35.7%)和隐球菌病(n = 3;10.7%)是确诊和疑似IFD组中最常见的真菌感染。13例(46.4%)发生霉菌感染。再次手术、roux-en-y吻合术以及术中大量输注≥40单位细胞血制品是多因素分析中IFD的主要危险因素。
念珠菌和曲霉是我们中心肝移植中IFD最常见的病因。移植后此类感染的危险因素有显著重叠。在我们的队列中,围手术期病程复杂的重症患者似乎使其易发生移植后霉菌感染,但需要更大规模的研究来更好地描述霉菌感染的危险因素以及确定肝移植中霉菌预防的疗效和最佳持续时间。随着棘白菌素用于抗真菌预防的增加,监测新出现的抗真菌耐药性也很重要。